Announcement

TOTAL14 (1/1 page)

공지사항 목록
Date Type Title
2022-07-01 NEWS
Cell & Gene Therapy World Asia Conference 2022

Seong-Wook, Lee, President & CEO of Rznomics inc., will share his insight on the following subject;- Conference: Cell & Gene Therapy World Asia Conference 2022- Date:  12:00, September 14 2022- Topic : Gene Therapeutics Through Ribozyme-Mediated RNA Editing StrategyPlease refer to attachment for details.

2022-07-01 NEWS
Cell & Gene Therapy Summit Conference 2022

Seong-Wook, Lee, President & CEO of Rznomics inc., will share his insight on the following subject;- Conference: Cell & Gene Therapy Summit Conference 2022- Date:  14:30, July 20 2022- Topic : Merging Technologies in Gene Therapy DevelopmentPlease refer to attachment for details.

2022-06-15 NEWS
Biologistics World Korea Conference 2022

Seong-Wook, Lee, President & CEO of Rznomics inc., will share his insight on the following subject;- Conference: Biologistics World Korea Conference 2022- Date:  09:30, June 29 2022- Topic : Development of Gene Therapies Based On Ribozyme-mediated RNA Editing StrategyPlease refer to attachment for details.

2022-06-14 NEWS
KMB Annual Meeting & International Symposium 2022

Seong-Wook, Lee, President & CEO of Rznomics inc., will share his insight on the following subject;- Conference: 49th KMB Annual Meeting & International Symposium- Date:  09:00~11:00, June 24, 2022- Session: Current Status and Future Perspectives on Gene Therapy in Korea- Topic : Gene Therapeutics through RNA Editing Approach Based on Tetrahymena Group I IntronPlease refer to attachment for details.

2022-05-30 NEWS
2022년도 생화학분자생물학회 국제학술대회 발표

알지노믹스(주) 이성욱 대표이사는 2022년 5월 25일 진행된 생화학분자생물학회 국제학술대회에 참여하여 아래 주제로 발표를 진행했습니다.- 일시 : 2022년 05월 25일(수) 09:00 - 09:25- 세션 : Venture Capital and Biopharmaceutical Industry(2) - Cell and Gene Therapy- 주제 : Gene Therapeutics using RNA editing strategy based on trans-splicing ribozyme 자세한 내용은 첨부파일 내 포스터를 참고해주시기 바랍니다.

2021-11-15 NEWS
2021 한국유전자세포치료학회(KSGCT) 우수 포스터 선정(RNA replacement)

알지노믹스(주)의 연구진(이성욱 대표, 한승렬 박사, 김지현 박사)이 참여한 학술 포스터 'RNA replacement based on trans-splicing ribozyme for hepatocellular carcinoma gene therapy'가 2021 제16회 한국유전자세포치료학회에서 우수 포스터(KSGCT Poster Prize)로 선정되었습니다. ​

2021-11-15 NEWS
KSGCT 정기 학술대회 Education 세션 발표

알지노믹스㈜ 이성욱 대표이사는 지난 11월 4일부터 진행된 KSGCT 정기 학술대회에 연사로 참석하여 아래 주제로 발표를 진행하였습니다. - 행사명 : 16th KSGCT 정기 학술대회(KSGCT·Korean Society of Gene and Cell Therapy)- 발표세션 : Education 내 'Education – Start – ups from KSGCT'- 주제 : 라이보자임 매개 RNA 편집기술 기반 유전자치료제 개발(Gene Therapeutics through Ribozyme-mediated RNA Editing Platform)- 일시 : 2021년 11월 05일(금) 10:45자세한 내용은 첨부파일 내 포스터를 참고해주시기 바랍니다.

2021-11-15 NEWS
Cell & Gene Therapy World Asia 2021 Conference

Seong-Wook, Lee, President & CEO of Rznomics inc., has shared his insight on the following subject as keynote speaker and gene-therapy expert at Cell & Gene Therapy World Asia 2021 Conference.- Conference: Cell & Gene Therapy World Asia 2021- Topic: Gene Therapeutics Through Ribozyme-mediated RNA Editing Strategy 1) Gene therapy  2) RNA editing  3) Trans-splicing ribozyme- Date: September 15-16, 2021Please refer to attachment for details.

2021-11-15 NEWS
2021 한국유전자세포치료학회(KSGCT) 우수 포스터 선정(Anti-cancer)

알지노믹스(주)의 연구진(이성욱 대표, 박혜림 박사)이 참여한 학술 포스터 'Anti-cancer effects of ribozyme-mediated RNA replacement combined with cancer immunotherapy for hepatocarcinoma cancer'가 2021 제16회 한국유전자세포치료학회에서 우수 포스터(KSGCT Poster Prize)로 선정되었습니다. 

2020-11-18 NEWS
2020 한국유전자세포치료학회(KSGCT) 우수 포스터 선정

알지노믹스(주)의 연구진(이성욱 대표, 한승렬 박사, 김지현 박사)이 참여한 학술 포스터 'Cancer control through CRISPRi mediated epigenetic editing of mutant TERT promoter'가2020 제15회 한국유전자세포치료학회에서 우수 포스터(KSGCT Poster Prize - Poster Presentation)로 선정되었습니다.